Jean‐Marc Lapierre
Cyteir Therapeutics (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Dendrimers and Hyperbranched Polymers, Asymmetric Synthesis and Catalysis, PI3K/AKT/mTOR signaling in cancer, Synthesis and biological activity
Most-Cited Works
- → Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists(2000)248 cited
- → Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor(2016)105 cited
- → Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors(2012)99 cited
- → Chiral Dendrimers from Tris(hydroxymethyl)methane Derivatives(1994)87 cited
- → Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation(2016)84 cited
- → Synthesis of Chiral Starburst Dendrimers from PHB‐Derived Triols as Central Cores(1994)75 cited
- → Chirale Tris(hydroxymethyl)methan‐Derivate als Synthesebausteine für chirale Dendrimere(1994)43 cited
- → Preparation of Chiral Building Blocks for Starburst Dendrimer Synthesis(1993)42 cited
- → Synthesis and Properties of First and Second Generation Chiral Dendrimers with Triply Branched Units: A Spectacular Case of Diastereoselectivity(1997)36 cited
- → A Simple Procedure for the Preparation of Chiral ‘Tris(hydroxymethyl)methane’ Derivatives(1993)33 cited